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Summary
Bacteraemia is a leading cause of morbidity in sickle cell anaemia (SCA), but infor-
mation from studies in Africa is limited. We evaluated 890 admissions from 648
SCA patients at a tertiary hospital in Tanzania. Bacteraemia was present in 43
admissions (48%); isolates included Staphylococcus aureus (12/43; 28%), non-Typhi
Salmonella (9/43; 21%), Streptococcus pneumoniae (3/43; 7%) and Salmonella Typhi
(2/43; 5%). Compared to SCA patients without bacteraemia, SCA patients with bac-
teraemia had significantly lower haemoglobin [71 g/l vs. 62 g/l, odds ratio 072
(95% confidence interval 056–091), P < 001]. Further exploration is needed of
the relationship between anaemia and bacterial infections in SCA in Africa.
Keywords: bacteraemia, sickle cell anaemia, haemoglobin, admission,
Africa.
Individuals with sickle cell anaemia (SCA) are at an increased
risk of invasive bacterial infections (Ramakrishnan et al,
2010). In the absence of preventions, bacterial infections are
the leading cause of mortality in individuals with SCA, with
the proportion of deaths from infection reported to be as high
as 38% in the United States (Leikin et al, 1989) and 29% in
Jamaica (Lee et al, 1995). Interventions with penicillin and
vaccination against pneumococcal infections have successfully
reduced mortality in these settings (Gaston et al, 1986;
Knight-Madden & Serjeant, 2001; Halasa et al, 2007). These
interventions are not part of standard treatment and preven-
tion for SCA in much of sub-Saharan Africa, where the burden
of SCA is highest. This is partly due to paucity of empirical
data on the magnitude and pattern of bacteraemia in SCA
(Obaro, 2009; Ramakrishnan et al, 2010). Nevertheless, studies
from Kenya and Uganda have reported bacteraemia as a signif-
icant cause of morbidity in hospitalized SCA patients (Kizito
et al, 2007; Williams et al, 2009). However, these studies are
limited by the small number of SCA patients studied: 197 in
Kenya (Williams et al, 2009) and 165 in Uganda (Kizito et al,
2007). In 2004, a SCA programme was established in Dar-es-
Salaam, Tanzania, with prospective surveillance of one of the
largest, single-centre cohorts of SCA patients in Africa (Mak-
ani et al, 2011). Here, we present the prevalence and pattern
of bacteraemia among 648 SCA patients who were admitted to
a tertiary-level hospital in an urban setting over a 3-year per-
iod, between 1 January 2006 and 31 December 2008.
Methods
Study site and recruitment
The study was conducted at Muhimbili National Hospital
(MNH) in Tanzania. This is the tertiary-level, referral hospital
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for all individuals with SCA in Dar-es-Salaam. Standard care
for SCA includes daily folic acid supplementation and treat-
ment of malaria with artemisinin-based combination therapy
(for uncomplicated malaria) and quinine (for severe compli-
cated malaria). Chloroquine was recommended, but was not
offered to study subjects for malaria prophylaxis. Penicillin
prophylaxis and pneumococcal vaccines were not the stan-
dard of care during the study period and were thus not
offered to any study subject. The current study involved daily
surveillance and enrolment of all SCA patients (known or
suspected) who were admitted to the paediatric and adult
medical wards during the study period. Enrolment was irre-
spective of clinical features at, and reason for admission. Eth-
ical approval was given by Muhimbili University of Health
and Allied Sciences (MUHAS; reference MU/RP/AEC/VOL
XI/33) (Makani et al, 2011). Written informed consent was
obtained from parents or guardians of children and from
patients who were above 18 years of age.
Laboratory methods
Sickle cell anaemia (SCA) was diagnosed using alkaline hae-
moglobin electrophoresis (Helena, Sunderland, UK) and high
performance liquid chromatography (HPLC; Bio-Rad, Her-
cules, CA, USA). In order to identify community- and not
hospital- acquired bacteraemia, blood cultures were done
within 24 h of hospitalization before antibiotics were given.
Between 2 and 4 ml of venous blood for culture was col-
lected from all study subjects by trained technicians using
standard aseptic techniques, and cultures were performed
using the BACTEC system (BACTEC; Becton Dickinson,
Franklin Lakes, NJ, USA). The BACTEC bottles were weighed
before and after inoculation for quality control. Positive
blood cultures were sub-cultured on standard media with the
use of routine microbiological techniques. Positive quality
control systems were done on the blood culture bottles as
well as the media for sub-culture to ensure growth of fastidi-
ous organisms. Once obtained, blood culture results were
communicated to inpatient care physicians. Blood counts
were performed with an automated cell counter (ABX Pentra
60, Horiba, Japan). Reticulocyte counts were performed
using the new methylene blue method. Tests for liver and
renal functions were done using an automated chemistry
analyser (Roche Cobas Mira, New York, USA or Abbott
Architect, New York, USA).
Statistical methods
Data were analysed using STATA v10 (StataCorp, College
Station, TX, USA). Each hospitalization was taken as a sepa-
rate event, with some individuals being hospitalized more
than once. The prevalence of bacteraemia was defined as the
proportion of positive blood cultures in all blood cultures
taken. 100 blood cultures (112%) grew non-pathogenic
organisms (contaminants) and were considered negative dur-
ing analysis. These included coagulase-negative Staphylococcus
aureus (88), Bacillus species (11) and Micrococcus species (1).
To determine factors associated with bacteraemia during hos-
pitalization, the clinical and laboratory features of those with
bacteraemia were compared to those without bacteraemia. In
univariate analysis, multiple events with clustering of events
within individuals were taken into account by applying a
random effects model. P values of <005 were considered sta-
tistically significant.
Results and discussion
Measuring the magnitude of bacterial infections in patients
with SCA is critical for our efforts at reducing the morbid-
ity and mortality in SCA. Here, we evaluated a total of 890
hospitalizations from 648 patients with SCA at a tertiary
hospital in Tanzania (median age 8 years; range 1–
43 years). The top three causes of admission in this cohort
were pain, fever and anaemia. Bacteraemia was found in
48% of admissions. Staphylococcus aureus and non-Typhi
Salmonella were the most common isolates, although other
bacteria, including Streptococcus pneumonia and Salmonella
Typhi, were also isolated (Table I). Compared to SCA
patients without bacteraemia, presence of bacteraemia in
SCA was significantly associated with lower haemoglobin
[71 g/l vs. 62 g/l, odds ratio 072 (95% CI 056–091),
P < 001]. SCA patients with bacteraemia were more likely
to have symptoms of anaemia (easy fatiguability, palpita-
tion, dizziness and headache), palpable liver and higher
serum creatinine, although these associations did not reach
statistical significance (Table II).
To our knowledge, our study is the first large-scale, hospi-
tal-based evaluation of bacteraemia in SCA in sub-Saharan
Africa (Ramakrishnan et al, 2010). Blood cultures were taken
for all study subjects (known or suspected to have SCA)
regardless of the presence of symptoms and signs suggestive of
infection. This was justified by the high risk of bacteraemia
among SCA patients reported in other studies (Zarkowsky
et al, 1986; Wierenga et al, 2001; Williams et al, 2009; Rama-
krishnan et al, 2010) as well as the tertiary-level hospital study
setting. The prevalence of bacteraemia reported in this study is
similar to that observed in other SCA populations, including
66% in Kenya, 61% in Jamaica and 52% in the United States
(Zarkowsky et al, 1986; Wierenga et al, 2001; Williams et al,
2009). The median age of the SCA population presented in this
study was 8 years. This may account for the relatively infre-
quent isolation of Streptococcus pneumoniae, which is more
prevalent among the younger SCA patients, predominantly
those below 3 years of age (Zarkowsky et al, 1986).
In our study, SCA patients with bacteraemia were more
likely to have symptoms of anaemia (easy fatiguability, palpi-
tation, dizziness and headache) and had much lower haemo-
globin levels during hospitalization. This is an important
finding as anaemia was reported to be significantly associated
with mortality in this setting (Makani et al, 2011). Further
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research is needed to explore the cause–effect relationship of
anaemia and bacteraemia in this setting.
However, there are limitations to our study. First, the pro-
portion of febrile patients and magnitude of bacteraemia
reported in this study could be an underestimation because of
potential prior usage of antipyretics and/or antibiotics at pri-
mary and secondary care facilities before referral to MNH. On
the other hand, there may be a referral bias as patients with a
Table II. Clinical and laboratory features in individuals with sickle cell anaemia associated with bacteraemia during hospitalization.
No bacteraemia
[n = 847/890 (952)]
Bacteraemia
[n = 43/890 (48)] OR (95% CI) P
Age, years, GM  SD 104  84 104  98 100 (096–104) 099
Symptoms
Fever, n/n (%) 137/600 (228) 9/25 (360) 190 (078–463) 016
Pain, n/n (%) 187/478 (391) 11/23 (478) 143 (061–336) 042
Symptoms of anaemia,* n/n (%) 50/600 (83) 5/25 (200) 275 (098–773) 006
Jaundice, n/n (%) 39/595 (66) 4/25 (160) 272 (090–817) 008
Examination
Jaundice, n/n (%) 430/630 (683) 20/28 (714) 116 (049–273) 073
Pallor, n/n (%) 284/589 (482) 12/25 (480) 099 (046–213) 098
Temperature, GM  SD 367  07 369  10 157 (094–262) 008
Febrile (>375°C), n/n (%) 64/627 (102) 4/25 (160) 168 (058–485) 033
SpO2, GM  SD 977  28 984  22 112 (093–135) 022
Palpable spleen, n/n (%) 129/588 (219) 4/26 (154) 065 (022–194) 044
Palpable liver, n/n (%) 43/551 (78) 3/25 (120) 161 (045–572) 005
Laboratory features
White blood cell count, 9109/l, GM  SD 185  116 230  159 102 (099–105) 006
Haemoglobin, g/l, GM  SD 71  16 62  18 072 (056–091) <001
Mean corpuscular volume, fl, GM  SD 806  99 821  108 101 (097–106) 049
Red cell distribution width, %, GM  SD 227  43 226  41 099 (090–109) 089
Platelet count, 9109/l, GM  SD 3992  2061 3711  1677 099 (099–100) 047
Reticulocyte count, %, GM  SD 139  66 139  79 100 (093–107) 098
Bilirubin – Total, lmol/l, GM  SD 676  715 496  341 099 (098–100) 023
Bilirubin – Unconjugated, lmol/l, GM  SD 532  413 304  428 099 (098–100) 018
Aspartate transaminase, iu/l, GM  SD 561  413 562  295 100 (099–101) 098
Alkaline phosphatase, iu/l, GM  SD 2657  1443 2259  1196 099 (099–100) 028
Creatinine, lmol/l, GM  SD 424  269 584  518 101 (100–102) 005
Lactate dehydrogenase, iu/l, GM  SD 10682  6109 11414  4711 100 (099–100) 055
Haemoglobin F, %, GM  SD 68  52 79  64 104 (096–112) 033
GM, geometric mean; SD, standard deviation; SpO2, peripheral oxygen saturation; OR, odds ratio; CI, confidence interval.
*Symptoms of anaemia included easy fatiguability, palpitation, dizziness and headache.
Table I. Bacterial isolates from blood of
patients with sickle cell anaemia during 890
hospitalizations at Muhimbili National
Hospital.
Bacterial isolate Isolates (n)
Percent
(1009 n/43)
Bacteraemia
(1009 n/890)
Staphylococcus aureus 12 279 13
Non-Typhi Salmonella 9 209 10
Streptococcus pneumonia 3 70 03
Streptococcus species 3 70 03
Escherichia coli 3 70 03
Klebsiella species 3 70 03
Pseudomonas species 3 70 03
Salmonella Typhi 2 47 02
Proteus species 2 47 02
Acinetobacter species 1 23 01
Aeromonas salmonicida 1 23 01
Morganella morganii 1 23 01
Total number of isolates 43 100 48
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known diagnosis of SCA may be more likely to seek care, lead-
ing to overestimation of bacteraemia. Second, the pattern of
bacteraemia, particularly prevalence of S. pneumoniae, may
have also been influenced by survival bias, as high-risk children
below 3 years of age may have died of pneumococcal bactera-
emia before diagnosis of SCA or referral to the tertiary hospi-
tal. Further studies are needed to determine the prevalence and
pattern of bacteraemia in SCA in different age groups and at
primary and secondary health care facilities. Third, our surveil-
lance of adult patients was limited to the medical, but not sur-
gical wards, and thus may have missed adult SCA patients
admitted to surgical wards with infective processes such as cel-
lulitis and infected leg ulcers. Finally, the contamination rate
of blood cultures in our study was high. 112% of blood cul-
tures performed grew contaminants and were considered nega-
tive during analysis. Though similar to the rate of
contamination reported in other studies (Kenyon et al, 2012),
this may have lead to underestimation of the magnitude of
bacteraemia in our cohort.
In summary, we have reported the prevalence of bactera-
emia in hospitalized SCA patients from one of the largest
studies of SCA in sub-Saharan Africa. The prevalence as well
as pattern of bacteraemia observed in our study is similar to
that reported in other SCA populations. Presence of bactera-
emia in SCA appears to be associated with lower haemoglo-
bin. Further research is needed to explore the cause–effect
relationship as well as the mechanisms of anaemia in SCA
patients with bacterial infections. Furthermore, clinical trials
are needed to determine locally appropriate interventions,
particularly prevention (chemoprophylaxis and vaccination)
as well as empirical antibiotics for treatment of individuals
with SCA who are admitted to hospital with bacteraemia.
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